Medplus Health Services Ltd.

View in App
696.20 +5.45 ▲0.8%

18 April 2024, 04:01:00 PM
Volume: 2,944

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.medplusindia.com
Market Cap 8,256.42 Cr.
Enterprise Value(EV) 8,061.00 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 4.91 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 140.76 Trailing Twelve Months Ending 2023-12
Industry PE 41.15 Trailing Twelve Months Ending 2023-12
Book Value / Share 128.89 Trailing Twelve Months Ending 2023-12
Price to Book Value 5.36 Calculated using Price: 690.70
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 11.95 Cr. 119,536,952 Shares
FaceValue 2
About Medplus Health Services Ltd.
MedPlus is one of India's leading healthcare companies with an ever-growing number of pharmacy stores, online pharmacy, path labs and optical services.

Medplus Health Services Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Medplus Health Services Ltd. Performance

View details >>
1 Day
+0.79%
1 Week
+3.22%
1 Month
+4.15%
3 Month
-5.86%
6 Month
-8.96%
1 Year
-2.77%
2 Year
-29.71%
5 Year
10 Year

Medplus Health Services Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 5.51 6.78 21.06 19.26 6.81 0.43 10.51 9.07 3.5
Return on Capital Employed (%) 10.02 12.04 20.61 13.06 11.77 14.34 21.69 16.56 9.56
Return on Assets (%) 1.73 1.94 5.62 7.47 3.26 0.18 4.31 4.51 1.86

Medplus Health Services Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 154 149 160 303 325 528 731 1,418 1,491 1,523
Non Curr. Liab. 66 82 88 -19 10 327 400 647 797 800
Curr. Liab. 210 269 276 325 337 498 445 559 477 545
Minority Int. 0 0 0 0 0 1 1 -1 -1 -1
Equity & Liab. 430 501 525 610 672 1,354 1,575 2,624 2,764 2,867
Non Curr. Assets 113 125 130 152 197 521 622 992 1,284 1,305
Curr. Assets 317 376 395 458 475 833 953 1,632 1,481 1,561
Misc. Exp. not W/O
Total Assets 430 501 525 610 672 1,354 1,575 2,624 2,764 2,867

Medplus Health Services Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 1,368 1,733 2,011 2,132 2,273 2,871 3,069 3,779 4,558 5,387
Other Income 4 9 8 7 10 17 22 31 46 43
Total Income 1,373 1,742 2,020 2,139 2,283 2,888 3,091 3,811 4,604 5,431
Total Expenditure -1,333 -1,691 -1,935 -2,073 -2,216 -2,737 -2,840 -3,490 -4,276 -5,058
PBIDT 40 50 85 66 67 151 251 320 327 373
Interest -17 -22 -25 -28 -16 -47 -67 -83 -99 -94
Depreciation -9 -10 -11 -12 -14 -75 -88 -119 -182 -221
Taxation -6 -10 -19 17 -16 -28 -32 -23 3 0
Exceptional Items
PAT 7 9 29 42 21 2 63 95 50 59
Minority Interest 1 1 0 0
Share Associate
Other Related Items
Consolidated Net Profit 7 9 29 42 21 2 64 96 50 59
Adjusted EPS 39 48 152 194 96 8 285 8 4 5

Medplus Health Services Ltd. Cash Flow

View details >>
Particulars 9 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -19 -17 34 32 82 -7 3 170 90
Cash Fr. Inv. -15 -32 -15 -18 -20 -28 -35 -703 429
Cash Fr. Finan. 66 35 -29 -1 -72 90 -6 440 -170
Net Change 32 -15 -10 14 -10 56 -37 -93 350
Cash & Cash Eqvt 45 31 21 35 24 9 -28 -121 228

Medplus Health Services Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 40.43 40.43 40.43 40.43 40.43 40.43 40.41 40.45 40.39
Public 59.57 59.57 59.57 59.57 59.57 59.57 59.59 59.55 59.61
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 26.91 53.81 50.53 50.53 50.53 50.53 50.53 58.05 54.17
No. of Shareholders (in Lacs)

Medplus Health Services Ltd. Announcements

View details >>
Tue, 16 Apr 2024
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
One of our subsidiary has received orders from Assistant Director & Drug Control Administration Authority. The detailed disclosure is enclosed.
Mon, 15 Apr 2024
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
One of our subsidiary has received certain orders from Assistant Drug Commissioner Drugs Control Administration. The detailed disclosure is enclosed.
Sat, 13 Apr 2024
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
One of our subsidiary has received order from Directorate of Drug Control Authority. The detailed disclosure is enclosed.

Medplus Health Services Ltd. Technical Scans

View details >>
Tue, 16 Apr 2024
Opening at High Opening at High
Closing Above Previous High Closing Above Previous High
CCI Trending Up CCI Trending Up
RSI Trending Up RSI Trending Up
William %R Trending Up William %R Trending Up

Medplus Health Services Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 368,765.79 1,523.80 -0.9%
Cipla Ltd. 111,101.58 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. 100,958.41 5,959.10 -1.5%
Divi's Laboratories Ltd. 99,939.63 3,717.35 -1.3%
Zydus Lifesciences Ltd. 95,104.21 934.50 -1.1%
Mankind Pharma Ltd. 91,420.29 2,397.40 +5.0%
Apollo Hospitals Enterprise Ltd. 91,073.20 6,107.00 -3.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.41 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-12 29.96 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.31 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-12 72.26 3,717.35 -1.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.98 934.50 -1.1%
Mankind Pharma Ltd. Consolidated 2023-12 52.93 2,397.40 +5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.38 6,107.00 -3.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.91 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-12 4.29 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.76 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-12 7.67 3,717.35 -1.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.05 934.50 -1.1%
Mankind Pharma Ltd. Consolidated 2023-12 10.29 2,397.40 +5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.48 6,107.00 -3.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-03 0.02 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,717.35 -1.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 934.50 -1.1%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,397.40 +5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,107.00 -3.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,717.35 -1.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 934.50 -1.1%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,397.40 +5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,107.00 -3.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,717.35 -1.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 934.50 -1.1%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,397.40 +5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,107.00 -3.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,717.35 -1.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 934.50 -1.1%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,397.40 +5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,107.00 -3.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,717.35 -1.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 934.50 -1.1%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,397.40 +5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,107.00 -3.6%

Medplus Health Services Ltd. FAQ's

What is Medplus Health Servi share price?
Can I buy Medplus Health Servi shares now?
What is the Market Cap of Medplus Health Servi?
What are the key metrics to analyse Medplus Health Servi?
What is the 52 Week High and Low of Medplus Health Servi?
What is the trend of Medplus Health Servi share price?